Optical Imaging Company Appoints CEO

BioAxial, a key player in live cell super resolution microscopy, has announced the appointment of Georges Tabary as its president and chief executive officer. The Paris-based company develops imaging instruments for fluorescence microscopy that allow extended imaging of live cells without damaging them.
 

In 2013 the company raised €1.9m ($2.1m) funding from Amorçage Technologique Investissement (a fund managed by CEA Investissement), Inserm Transfert Initiative and ACG Management (formerly Viveris Management) and other individual investors.
 

“We are thrilled to welcome Georges to this key leadership position,” said Frank Lison, PhD, chairman of BioAxial. “He has a proven track record developing new businesses and leading sales and marketing strategy for pioneering and highly advanced life science technology companies, such as Leica Microsystems, Intuitive Surgical, Technomed International, ELA Medical and Mauna Kea.”
 

“We are enthusiastic about Georges joining; with his outstanding experience he will bring strategic leadership and market knowledge,” said Gabriel Sirat and Louis-Philippe Braitbart, co-founders of BioAxial. “His deep understanding of business needs will be instrumental in taking our company to the next level and we are determined to give him our full support and commitment to succeed as a team.”
 

“I am delighted to be joining the BioAxial team,” said Georges Tabary. “The super-resolution microscopy industry is today one of the fastest growing, supported by strong demand from life science companies. Microscopy is a key tool in the life science industry as it helps to accelerate research by combining scientific knowledge and technological know-how.”